Skip to main content

Advertisement

Log in

Lower Urinary Tract Symptoms in Women with Diabetes Mellitus: A Current Review

  • Lower Urinary Tract Symptoms & Voiding Dysfunction (H Goldman and G Badlani, Section Editors)
  • Published:
Current Urology Reports Aims and scope Submit manuscript

Abstract

A literature review of the most current publications studying lower urinary tract symptoms (LUTS) and findings in diabetic women was conducted including articles from January 2013 to April 2014. Current reports consistently note that aging and obesity are significantly associated with worsened LUTS in diabetic women. Glucosuria has variable effects on urodynamic parameters and LUTS, but has a significant association with urinary tract infection (UTI) and incontinence at clinically relevant numbers, such as HbA1C values. The presence of severe nocturia in diabetic patients warrants careful surveillance for cardiovascular risks given the significant association with mortality. Diabetics appear to be at higher risk for colonization with the virulent, extended-spectrum, β-lactamase-producing Escherichia coli and Klebsiella species in UTI. Novel therapies in glycemic control and for diabetic bladder dysfunction are undergoing animal model trials with encouraging results. The most promising of these includes stem cell therapy, although a need exists for human studies.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. Samsioe G, Heraib F, Lidfeldt J, et al. Urogenital symptoms in women aged 50-59 years. Women's Health in Lund Area (WHILSA) Study Group. Gynecol Endocrinol Off J Int Soc Gynecol Endocrinol. 1999;13(2):113–7.

    Article  CAS  Google Scholar 

  2. Brown JS, Seeley DG, Fong J, Black DM, Ensrud KE, Grady D. Urinary incontinence in older women: who is at risk? Study of Osteoporotic Fractures Research Group. Obstet Gynecol. 1996;87(5 Pt 1):715–21.

    Article  PubMed  CAS  Google Scholar 

  3. Farrell SA, Allen VM, Baskett TF. Parturition and urinary incontinence in primiparas. Obstet Gynecol. 2001;97(3):350–6.

    Article  PubMed  CAS  Google Scholar 

  4. Brown JS, Vittinghoff E, Lin F, Nyberg LM, Kusek JW, Kanaya AM. Prevalence and risk factors for urinary incontinence in women with type 2 diabetes and impaired fasting glucose: findings from the National Health and Nutrition Examination Survey (NHANES) 2001-2002. Diabetes Care. 2006;29(6):1307–12.

    Article  PubMed  PubMed Central  Google Scholar 

  5. Brown JS, Wing R, Barrett-Connor E, et al. Lifestyle intervention is associated with lower prevalence of urinary incontinence: the Diabetes Prevention Program. Diabetes Care. 2006;29(2):385–90.

    Article  PubMed  PubMed Central  Google Scholar 

  6. Foldspang A, Hvidman L, Mommsen S, Nielsen JB. Risk of postpartum urinary incontinence associated with pregnancy and mode of delivery. Acta Obstet Gynecol Scand. 2004;83(10):923–7.

    Article  PubMed  CAS  Google Scholar 

  7. Ebbesen MH, Hannestad YS, Midthjell K, Hunskaar S. Diabetes and urinary incontinence - prevalence data from Norway. Acta Obstet Gynecol Scand. 2007;86(10):1256–62.

    Article  PubMed  Google Scholar 

  8. Danforth KN, Townsend MK, Lifford K, Curhan GC, Resnick NM, Grodstein F. Risk factors for urinary incontinence among middle-aged women. Am J Obstet Gynecol. 2006;194(2):339–45.

    Article  PubMed  PubMed Central  Google Scholar 

  9. Benfield T, Jensen JS, Nordestgaard BG. Influence of diabetes and hyperglycaemia on infectious disease hospitalisation and outcome. Diabetologia. 2007;50(3):549–54.

    Article  PubMed  CAS  Google Scholar 

  10. Simkhada R. Urinary tract infection and antibiotic sensitivity pattern among diabetics. Nepal Med Coll J NMCJ. 2013;15(1):1–4.

    CAS  Google Scholar 

  11. Patterson JE, Andriole VT. Bacterial urinary tract infections in diabetes. Infect Dis Clin N Am. 1997;11(3):735–50.

    Article  CAS  Google Scholar 

  12. Kesah CN, Coker AO, Alabi SA, Olukoya DK. Prevalence, antimicrobial properties and beta-lactamase production of haemolytic enterobacteria in patients with diarrhoea and urinary tract infections in Legos, Nigeria. Cent Afr J Med. 1996;42(5):147–50.

    PubMed  CAS  Google Scholar 

  13. Muller LM, Gorter KJ, Hak E, et al. Increased risk of common infections in patients with type 1 and type 2 diabetes mellitus. Clin Infect Dis Off Publ Infect Dis Soc Am. 2005;41(3):281–8.

    Article  CAS  Google Scholar 

  14. Bani-Issa W, Almomani F, Eldeirawi K. Urinary incontinence among adult women with diabetes in Jordan: epidemiology, correlates and perceived impact on emotional and social well-being. J Clin Nurs. 2013.

  15. Palleschi G, Pastore AL, Maggioni C, et al. Overactive bladder in diabetes mellitus patients: a questionnaire-based observational investigation. World J Urol. 2013.

  16. Ahmed HM, Osman VA, Al-Alaf SK, Al-Tawil NG. Prevalence of urinary incontinence and probable risk factors in a sample of kurdish women. Sultan Qaboos Univ Med J. 2013;13(2):269–74.

    Article  PubMed  PubMed Central  Google Scholar 

  17. Appa AA, Brown JS, Creasman J, et al. Clinical predictors and significance of postvoid residual volume in women with diabetes. Diabetes Res Clin Pract. 2013;101(2):164–9.

    Article  PubMed  PubMed Central  Google Scholar 

  18. Chung MS, Chuang YC, Lee JJ, Lee WC, Chancellor MB, Liu RT. Prevalence and associated risk factors of nocturia and subsequent mortality in 1,301 patients with type 2 diabetes. Int Urol Nephrol. 2014. The alarming significance between nocturia of ≥ 3 times per night and cardiovascular mortality in diabetic patients warrants a provider to urge the patient to maintain vigilant surveillance with her primary care provider in routine cardiovascular risk screenings. In a sense, the symptom of nocturia may prove to be a valuable warning in the care of diabetic patients.

  19. Deli G, Bosnyak E, Pusch G, Komoly S, Feher G. Diabetic neuropathies: diagnosis and management. Neuroendocrinology. 2013;98(4):267–80.

    Article  PubMed  CAS  Google Scholar 

  20. Lee WC, Wu HC, Huang KH, Wu HP, Yu HJ, Wu CC. Hyposensitivity of C-fiber afferents at the distal extremities as an indicator of early stages diabetic bladder dysfunction in type 2 diabetic women. PLoS One. 2014;9(1):e86463.

    Article  PubMed  PubMed Central  Google Scholar 

  21. Kirschner-Hermanns R, Daneshgari F, Vahabi B, Birder L, Oelke M, Chacko S. Does diabetes mellitus-induced bladder remodeling affect lower urinary tract function? ICI-RS 2011. Neurourol Urodyn. 2012;31(3):359–64.

    Article  PubMed  Google Scholar 

  22. Kim JH, Lee SR, Song YS, Lee HJ. Stem cell therapy in bladder dysfunction: where are we? And where do we have to go? BioMed Res Int. 2013;2013:930713. Stem cell therapy appears to have the most promising projection for future LUTS therapies, but focused efforts must be made to conduct human studies.

    PubMed  PubMed Central  Google Scholar 

  23. Daneshgari F, Liu G, Imrey PB. Time dependent changes in diabetic cystopathy in rats include compensated and decompensated bladder function. J Urol. 2006;176(1):380–6.

    Article  PubMed  Google Scholar 

  24. Daneshgari F, Huang X, Liu G, Bena J, Saffore L, Powell CT. Temporal differences in bladder dysfunction caused by diabetes, diuresis, and treated diabetes in mice. Am J Physiol Regul Integr Comp Physiol. 2006;290(6):R1728–35.

    Article  PubMed  CAS  Google Scholar 

  25. Hammar N, Farahmand B, Gran M, Joelson S, Andersson SW. Incidence of urinary tract infection in patients with type 2 diabetes. Experience from adverse event reporting in clinical trials. Pharmacoepidemiol Drug Saf. 2010;19(12):1287–92.

    Article  PubMed  Google Scholar 

  26. Kullmann FA, Wells GI, McKenna D, Thor KB. Excitatory effects of bombesin receptors in urinary tract of normal and diabetic rats in vivo. Life Sci. 2014;100(1):35–44.

    Article  PubMed  CAS  Google Scholar 

  27. Ren LM, Zhuo YJ, Hao ZS, He HM, Lu HG, Zhao D. Berberine improves neurogenic contractile response of bladder detrusor muscle in streptozotocin-induced diabetic rats. J Ethnopharmacol. 2013;150(3):1128–36.

    Article  PubMed  CAS  Google Scholar 

  28. Changxiao H, Zhengyong Y, Shibing Y, et al. Clinical and urodynamic evaluation of women referred with diabetes mellitus. Int Urogynecol J. 2014.

  29. Ding L, Song T, Yi C, et al. Transcutaneous electrical nerve stimulation (TENS) improves the diabetic cytopathy (DCP) via up-regulation of CGRP and cAMP. PLoS One. 2013;8(2):e57477.

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  30. Kaplan SA, Te AE, Blaivas JG. Urodynamic findings in patients with diabetic cystopathy. J Urol. 1995;153(2):342–4.

    Article  PubMed  CAS  Google Scholar 

  31. Starer P, Libow L. Cystometric evaluation of bladder dysfunction in elderly diabetic patients. Arch Intern Med. 1990;150(4):810–3.

    Article  PubMed  CAS  Google Scholar 

  32. Chang TC, Chang SR, Hsiao SM, Hsiao CF, Chen CH, Lin HH. Factors associated with fecal incontinence in women with lower urinary tract symptoms. J Obstet Gynaecol Res. 2013;39(1):250–5.

    Article  PubMed  Google Scholar 

  33. Stav K, Shilo Y, Zisman A, Lindner A, Leibovici D. Comparison of lower urinary tract symptoms between women with detrusor overactivity and impaired contractility, and detrusor overactivity and preserved contractility. J Urol. 2013;189(6):2175–8.

    Article  PubMed  Google Scholar 

  34. Aswani SM, Chandrashekar U, Shivashankara K, Pruthvi B. Clinical profile of urinary tract infections in diabetics and non-diabetics. Australas Med J. 2014;7(1):29–34. The above study discusses how diabetics appear to be at higher risk for the most virulent strains of the common UTI microbes (extended-spectrum, β-lactamase-producing Escherichia coli and Klebsiella species; ESBL-EK), so continued research in therapies against these strains is warranted. E. coli has shown maximum sensitivity to carbapenems and the least susceptibility to ampicillin.

    Article  PubMed  PubMed Central  Google Scholar 

  35. Mody L, Juthani-Mehta M. Urinary tract infections in older women: a clinical review. JAMA J Am Med Assoc. 2014;311(8):844–54.

    Article  CAS  Google Scholar 

  36. Tsai SW, Kung FT, Chuang FC, Ou YC, Wu CJ, Huang KH. Evaluation of the relationship between urodynamic examination and urinary tract infection based on urinalysis results. Taiwan J Obstet Gynecol. 2013;52(4):493–7.

    Article  PubMed  Google Scholar 

  37. Mamun Mahmud H, Qureshi S, Kumar D, Farman S. Pyuric diabetic patients: a tertiary centre experience from Karachi. Pak J Med Sci. 2014;30(1):77–80.

    PubMed  PubMed Central  Google Scholar 

  38. Macvane SH, Tuttle LO, Nicolau DP. Impact of extended-spectrum beta-lactamase-producing organisms on clinical and economic outcomes in patients with urinary tract infection. J Hosp Med Off Publ Soc Hosp Med. 2014;9(4):232–8. The above study discusses how diabetics appear to be at higher risk for the most virulent strains of the common UTI microbes (extended-spectrum, β-lactamase-producing Escherichia coli and Klebsiella species; ESBL-EK), so continued research in therapies against these strains is warranted. E. coli has shown maximum sensitivity to carbapenems and the least susceptibility to ampicillin.

    Article  Google Scholar 

  39. Johnsson KM, Ptaszynska A, Schmitz B, Sugg J, Parikh SJ, List JF. Urinary tract infections in patients with diabetes treated with dapagliflozin. J Diabetes Complicat. 2013;27(5):473–8.

    Article  PubMed  Google Scholar 

  40. Dixon L, Winkler M. Emphysematous cystitis: a tympanic bladder. BMJ Case Rep. 2013;2013.

  41. Hanna-Mitchell AT, Ruiz GW, Daneshgari F, Liu G, Apodaca G, Birder LA. Impact of diabetes mellitus on bladder uroepithelial cells. Am J Physiol Regul Integr Comp Physiol. 2013;304(2):R84–93.

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  42. Wai CY, Curto TM, Zyczynski HM, et al. Patient satisfaction after midurethral sling surgery for stress urinary incontinence. Obstet Gynecol. 2013;121(5):1009–16.

    Article  PubMed  PubMed Central  Google Scholar 

  43. Nicolle LE, Capuano G, Ways K, Usiskin K. Effect of canagliflozin, a sodium glucose co-transporter 2 (SGLT2) inhibitor, on bacteriuria and urinary tract infection in subjects with type 2 diabetes enrolled in a 12-week, phase 2 study. Curr Med Res Opin. 2012;28(7):1167–71.

    Article  PubMed  CAS  Google Scholar 

  44. Uzun H, Ogullar S, Sahin SB, et al. Increased bladder wall thickness in diabetic and nondiabetic women with overactive bladder. Int Neurourol J. 2013;17(2):67–72.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Compliance with Ethics Guidelines

Conflict of Interest

Dr. Rebecca James and Dr. Adonis Hijaz each declare no potential conflicts of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Rebecca James.

Additional information

This article is part of the Topical Collection on Lower Urinary Tract Symptoms & Voiding Dysfunction

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

James, R., Hijaz, A. Lower Urinary Tract Symptoms in Women with Diabetes Mellitus: A Current Review. Curr Urol Rep 15, 440 (2014). https://doi.org/10.1007/s11934-014-0440-3

Download citation

  • Published:

  • DOI: https://doi.org/10.1007/s11934-014-0440-3

Keywords

Navigation